BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease No … ← Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy →